These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18395477)

  • 1. Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis.
    Kadoglou NP; Gerasimidis T; Moumtzouoglou A; Kapelouzou A; Sailer N; Fotiadis G; Vitta I; Katinios A; Kougias P; Bandios S; Voliotis K; Karayannacos PE; Liapis CD
    Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):661-8. PubMed ID: 18395477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.
    Kadoglou NP; Gerasimidis T; Kapelouzou A; Moumtzouoglou A; Avgerinos ED; Kakisis JD; Karayannacos PE; Liapis CD
    Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):258-65. PubMed ID: 20004120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Liapis CD
    J Vasc Surg; 2010 Jan; 51(1):114-21. PubMed ID: 19837545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.
    Kadoglou NP; Gerasimidis T; Golemati S; Kapelouzou A; Karayannacos PE; Liapis CD
    J Vasc Surg; 2008 Jan; 47(1):55-62. PubMed ID: 18178454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of statins on levels of calcification biomarkers in patients with aortic sclerosis or mild aortic stenosis.
    Dimitrow PP; Jawień M; Gackowski A
    J Heart Valve Dis; 2011 Jan; 20(1):18-22. PubMed ID: 21404893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipokines: a novel link between adiposity and carotid plaque vulnerability.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Kostakis A; Liapis CD
    Eur J Clin Invest; 2012 Dec; 42(12):1278-86. PubMed ID: 23033969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin therapy is associated with improvement of oxidized low-density lipoprotein cholesterol levels, which correlates with the degree of stenosis in patients with carotid atheromatosis with and without prior angioplasty.
    Kougialis S; Skopelitis E; Gialernios T; Nikolaou S; Kroustalis A; Katsadorou E; Gialernios K; Zervou A; Gika E; Polydorou A; Polydorou V; Drakoulis C; Iliopoulos N; Dermitzakis I; Mpilinis H; Polydorou A
    Int Angiol; 2010 Aug; 29(4):338-47. PubMed ID: 20671652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound.
    Yamada K; Yoshimura S; Kawasaki M; Enomoto Y; Asano T; Minatoguchi S; Iwama T
    Cerebrovasc Dis; 2009; 28(4):417-24. PubMed ID: 19707015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin treatment and carotid plaque morphology in first-ever atherosclerotic transient ischemic attack/stroke: a case-control study.
    Marchione P; Vento C; Morreale M; Izzo C; Maugeri A; Manuppella F; Romeo T; Giacomini P
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):138-43. PubMed ID: 25440329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin therapy increases carotid plaque echogenicity in hypercholesterolemic patients.
    Yamagami H; Sakaguchi M; Furukado S; Hoshi T; Abe Y; Hougaku H; Hori M; Kitagawa K
    Ultrasound Med Biol; 2008 Sep; 34(9):1353-9. PubMed ID: 18378381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of fetuin-A, osteoprotegerin and osteopontin in patients with coronary artery disease: effects of statin (HMGCoA-reductase inhibitor) therapy.
    Kadoglou NP; Kottas G; Lampropoulos S; Vitta I; Liapis CD
    Clin Drug Investig; 2014 Mar; 34(3):165-71. PubMed ID: 24307429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.
    Cowell SJ; Newby DE; Prescott RJ; Bloomfield P; Reid J; Northridge DB; Boon NA;
    N Engl J Med; 2005 Jun; 352(23):2389-97. PubMed ID: 15944423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The short-term effect of atorvastatin on carotid plaque morphology assessed by computer-assisted gray-scale densitometry: a pilot study.
    Della-Morte D; Moussa I; Elkind MS; Sacco RL; Rundek T
    Neurol Res; 2011 Nov; 33(9):991-4. PubMed ID: 22081003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Sillesen H; Amarenco P; Hennerici MG; Callahan A; Goldstein LB; Zivin J; Messig M; Welch KM;
    Stroke; 2008 Dec; 39(12):3297-302. PubMed ID: 18845807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial.
    Houslay ES; Cowell SJ; Prescott RJ; Reid J; Burton J; Northridge DB; Boon NA; Newby DE;
    Heart; 2006 Sep; 92(9):1207-12. PubMed ID: 16449511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis.
    Lenglet S; Quercioli A; Fabre M; Galan K; Pelli G; Nencioni A; Bauer I; Pende A; Python M; Bertolotto M; Spinella G; Pane B; Palombo D; Dallegri F; Mach F; Vuilleumier N; Montecucco F
    Mediators Inflamm; 2014; 2014():720987. PubMed ID: 24648660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
    Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
    Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in flow-mediated dilatation, cytokines and carotid arterial stenosis during aggressive atorvastatin treatment in normocholesterolemic patients.
    Hsu HY; Wang PY; Chen YT; Sheu WH; Hu HH; Sheng WY
    J Chin Med Assoc; 2005 Feb; 68(2):53-8. PubMed ID: 15759815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease.
    Avellone G; Di Garbo V; Abruzzese G; Campisi D; De Simone R; Raneli G; Licata G
    Int Angiol; 2006 Mar; 25(1):26-34. PubMed ID: 16520721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of a regressive coronary soft plaque under lipid lowering therapy by multi-slice computed tomography.
    Burgstahler C; Reimann A; Beck T; Kuettner A; Heuschmid M; Kopp AF; Schroeder S
    Int J Cardiovasc Imaging; 2006 Feb; 22(1):119-21. PubMed ID: 16374526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.